Yelixza Avila

Ms. Yelixza Avila


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2021 in Molecules
Verified
Journal Article
Open access
PDF file
YAYelixza Avila
Yelixza Avila
MCMorgan Chandler
Morgan Chandler
ECEdward Cedrone
Edward Cedrone
HNHannah S. Newton
Hannah S. Newton
MRMelina Richardson
Melina Richardson
Marina DobrovolskaiaMarina Dobrovolskaia
Marina Dobrovolskaia
Recent insights into the immunostimulatory properties of nucleic acid nanoparticles (NANPs) have demonstrated that variations in the shape, size, and composition lead to distinct patterns in their immunostimulatory properties. While most of these studies have used a single lipid-based carrier to allow for NANPs’ intracellular delivery, it is now apparent that the platform for delivery, which has historically been a hurdle for therapeutic nucleic acids, is an additional means to tailoring NANP immunorecognition. Here, the use of dendrimers for the delivery of NANPs is compared to the lipid-based platform and the differences in resulting cytokine induction are presented.